Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$228K Sell
4,265
-4,320
-50% -$242K 0.05% 245
2014
Q3
$493K Sell
8,585
-16,966
-66% -$1.04M 0.09% 181
2014
Q2
$1.71M Sell
25,551
-259
-1% -$17.5K 0.32% 101
2014
Q1
$1.73M Sell
25,810
-1,179
-4% -$79.7K 0.32% 100
2013
Q4
$1.8M Sell
26,989
-4,715
-15% -$306K 0.32% 94
2013
Q3
$1.99M Sell
31,704
-5,661
-15% -$364K 0.35% 93
2013
Q2
$2.33M Buy
+37,365
New +$2.37M 0.49% 52

Other funds holding GSK

Robert N. Shapiro's GSK Position: Q4 2014 in Review

Robert N. Shapiro reduced its GSK (GSK) stake by 50% in Q4 2014, selling an estimated $242K and leaving 4,265 shares worth $228K. The position accounts for 0.05% of the portfolio, ranked #245.

Robert N. Shapiro first reported a position in GSK in Q2 2013 and has held it in 7 quarters since. The position peaked at $2.33M in Q2 2013. 728 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Robert N. Shapiro held 4,265 shares of GSK worth $228K as of Q4 2014.
  • Robert N. Shapiro sold 4,320 GSK shares in Q4 2014, an estimated $242K.
  • GSK made up 0.05% of Robert N. Shapiro's portfolio in Q4 2014, its #245 holding.
  • Robert N. Shapiro first reported a position in GSK in Q2 2013 and has held it in 7 quarters since.
  • Robert N. Shapiro's GSK position peaked at $2.33M in Q2 2013.
  • 728 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.